NO934357D0 - Fremgangsm}te for utvinning av proinsulin med korrekt forbundene cystinbruer - Google Patents

Fremgangsm}te for utvinning av proinsulin med korrekt forbundene cystinbruer

Info

Publication number
NO934357D0
NO934357D0 NO934357A NO934357A NO934357D0 NO 934357 D0 NO934357 D0 NO 934357D0 NO 934357 A NO934357 A NO 934357A NO 934357 A NO934357 A NO 934357A NO 934357 D0 NO934357 D0 NO 934357D0
Authority
NO
Norway
Prior art keywords
proinsulin
recovery
cystine bridges
linked cystine
properly linked
Prior art date
Application number
NO934357A
Other languages
English (en)
Other versions
NO308216B1 (no
NO934357L (no
Inventor
Rainer Obermeier
Martin Gerl
Juergen Ludwig
Walter Sabel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO934357D0 publication Critical patent/NO934357D0/no
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO934357L publication Critical patent/NO934357L/no
Publication of NO308216B1 publication Critical patent/NO308216B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO934357A 1992-12-02 1993-12-01 FremgangsmÕte for utvinning av proinsulin med korrekt forbundede cystinbroer NO308216B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4240420 1992-12-02

Publications (3)

Publication Number Publication Date
NO934357D0 true NO934357D0 (no) 1993-11-30
NO934357L NO934357L (no) 1994-06-03
NO308216B1 NO308216B1 (no) 2000-08-14

Family

ID=6474135

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934357A NO308216B1 (no) 1992-12-02 1993-12-01 FremgangsmÕte for utvinning av proinsulin med korrekt forbundede cystinbroer

Country Status (12)

Country Link
US (1) US5473049A (no)
EP (1) EP0600372B1 (no)
JP (1) JP2798351B2 (no)
AT (1) ATE148710T1 (no)
AU (1) AU662083B2 (no)
CA (1) CA2110442C (no)
DE (1) DE59305396D1 (no)
DK (1) DK0600372T3 (no)
ES (1) ES2097426T3 (no)
FI (1) FI108727B (no)
NO (1) NO308216B1 (no)
SG (1) SG46612A1 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
DE69637130T2 (de) * 1995-02-20 2008-02-21 The Walter And Eliza Hall Institute Of Medical Research, Parkville Immunoreaktive und immunotherapeutische moleküle welche in individuen mit insulin-abhängiger diabetes mellitus interagieren
SE9504019D0 (sv) * 1995-11-13 1995-11-13 Pharmacia Ab Method for production of proteins
DE59711533D1 (de) 1996-07-26 2004-05-27 Aventis Pharma Gmbh Insulinderivate mit erhöhter Zinkbindung
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
US6924120B1 (en) 1998-03-31 2005-08-02 Tonghua Gantech Biotechnology, Ltd. Chaperone protein containing an intramolecular chaperone-like sequence and its application to insulin production
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
CA2356109C (en) * 1999-01-06 2008-04-22 Genentech, Inc. Insulin-like growth factor (igf) i mutant variants
DE60042550D1 (de) * 1999-01-06 2009-08-27 Genentech Inc Mutierte varianten des insulin-ähnlichen wachstumsfaktor i (igf-i)
JP3406244B2 (ja) * 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
JP2003530316A (ja) 1999-12-22 2003-10-14 ノボ ノルディスク アクティーゼルスカブ スクランブルした一本鎖ポリペプチドの抽出的再生法
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
US20100152419A1 (en) * 2008-02-12 2010-06-17 Itoham Foods Inc. Fusion protein containing highly-expressed and secreted insulin precursor, dna encoding same, and method of producing insulin
US9296806B2 (en) * 2008-04-30 2016-03-29 Wockhardt Limited Processes for refolding of insulin
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
KR101853606B1 (ko) 2009-07-06 2018-05-03 사노피-아벤티스 도이칠란트 게엠베하 메티오닌을 함유하는 수성 인슐린 제제
DK2498802T3 (en) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Pharmaceutical composition comprising a GLP-1 agonist, insulin and a methionine
KR101337322B1 (ko) 2009-11-13 2013-12-06 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PL2750699T3 (pl) 2011-08-29 2015-12-31 Sanofi Aventis Deutschland Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US10421795B2 (en) 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
WO2015138548A1 (en) 2014-03-14 2015-09-17 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
AU2015359376B2 (en) 2014-12-12 2021-09-09 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196609A (en) 1980-03-27 1984-02-03 Lilly Co Eli Preparation of proinsulin-like insulin precursors
US4430266A (en) * 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor
NZ199391A (en) 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
DE3537708A1 (de) 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
DE4012818A1 (de) 1990-04-21 1991-10-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
DE3726655A1 (de) 1987-08-11 1989-02-23 Hoechst Ag Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten
DE58906966D1 (de) 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
GB8819826D0 (en) * 1988-08-20 1988-09-21 Kabivitrum Ab Glycosylated igf-1
DE3901719A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur herstellung eines insulinvorlaeufers
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
IL95495A (en) * 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use

Also Published As

Publication number Publication date
JP2798351B2 (ja) 1998-09-17
ES2097426T3 (es) 1997-04-01
FI935358A0 (fi) 1993-11-30
JPH06228191A (ja) 1994-08-16
FI935358L (fi) 1994-06-03
NO308216B1 (no) 2000-08-14
HK1006170A1 (en) 1999-02-12
EP0600372B1 (de) 1997-02-05
DE59305396D1 (de) 1997-03-20
SG46612A1 (en) 1998-02-20
NO934357L (no) 1994-06-03
CA2110442A1 (en) 1994-06-03
EP0600372A1 (de) 1994-06-08
DK0600372T3 (da) 1997-08-11
AU662083B2 (en) 1995-08-17
ATE148710T1 (de) 1997-02-15
FI108727B (fi) 2002-03-15
CA2110442C (en) 2004-05-04
AU5203993A (en) 1994-06-16
US5473049A (en) 1995-12-05

Similar Documents

Publication Publication Date Title
NO308216B1 (no) FremgangsmÕte for utvinning av proinsulin med korrekt forbundede cystinbroer
CA2142780A1 (en) Process for obtaining insulin having correctly linked cystine bridges
NO913186L (no) Fremgangsmaate for anvendelse og syntese av peptider.
DK0463450T3 (da) Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf
ATE212666T1 (de) Tnf-liganden
DE59409672D1 (de) Festphasensynthese von Oligoribonucleotiden
DE69606780D1 (de) Jod-enthaltende nitrile als kettenübertrager zur herstellung von perfluoropolymeren
DK96390A (da) Copoly-(arylensulfider) og fremgangsmaade til deres fremstilling
BR8600260A (pt) Processo para a preparacao de triacetoxissilanas a partir de tris(amino)silanas
BR9001703A (pt) Processo para separar glicina e sulfato de sodio decaidratado;processo para precipitar glicina e sulfato de sodio decaidratado;processo para a separacao continua de glicina e sulfato de sodio decaidratado;e processo para recuperar glicina
GR3017198T3 (en) Process for modification of a molecular sieve.
WO1994021812A3 (en) Hepatitis b escape mutant specific binding molecules
DK0612745T3 (da) Fremgangsmåde til fremstilling af 1,2,3,4,10,14b-hexahydro-2-methyl-dibenzo[c,f]pyrazino[1,2-a]azepin og salte deraf
DE3476390D1 (en) Chemical process
ATE118524T1 (de) Flüssige kohlenwasserstoffgemische mit hohen ein- und zweikernigen aromatenanteilen.
CA2150225A1 (en) A process for the purification of natural pulmonary surfactant material using supercritical fluids
KR960008941B1 (en) Dual combustion zone sulfur recovery process
Մուրադյան The Armenian Inscriptions from the Sinai. Edited by Michael E. Stone. With Appendixes by Michel van Esbroeck and Wiliam Adler. Harvard University Press Cambridge, Massachusetts, IX+ 197 p.+ CXXIII Pl.
PT81777A (en) Process for separating methyl isocyanate
IT1230519B (it) Miscela di caucciu' reticolabile, in particolare vulcanizzabile mediante zolfo.
DE3673641D1 (de) Methode zum straffziehen von zelten und hebelmechanismus zum ausfuehren dieser methode.